Literature DB >> 22553626

Bis(7)-tacrine protects retinal ganglion cells against excitotoxicity via NMDA receptor inhibition.

Zu-Hai Zhang1, Yu-Wei Liu, Fa-Gang Jiang, Xiang Tian, Yan-Hua Zhu, Jing-Bo Li, Qi Wang, Jia-Hua Fang.   

Abstract

AIM: To investigate whether bis(7)-tacrine, a multifunctional drug, inhibits N-methyl-D-aspartate (NMDA) -activated current in retinal ganglion cells(RGC) and provides neuroprotection against retinal cell damage.
METHODS: Purified RGC cultures were obtained from retinas of 1-3 days old Sprague-Dawley(SD) rats, following a two-step immunopanning procedure. After 7 days of cultivation, the inhibition of NMDA-activated current by bis(7)-tacrine was measured by using patch-clamp recording techniques. In animal experiments, RGCs were damaged after intravitreal injection of NMDA (5µL, 40nmol) in adult rats. Bis(7)-tacrine(0.05, 0.1, 0.2mg/kg) or memantine(20mg/kg) was intraperitoneal administered to the rats fifteen minutes before intravitreally injection of NMDA. RGC damage was analyzed by histologic techniques, TUNEL and retrograde labeling techniques.
RESULTS: Whole-cell patch-clamp recordings demonstrated that NMDA (30µmol/L) resulted in approximately -50 pA inward currents that were blocked by bis(7)-tacrine(1µmol/L). Histological examination and retrograde labeling analysis revealed that bis(7)-tacrine induced a significant neuroprotective effect against NMDA-induced cell damage 7 days after NMDA injection. TUNEL staining showed that pretreatment with bis(7)-tacrine was effective in ameliorating NMDA-induced apoptotic cell loss in the retinal ganglion cell layer 18 hours after injection.
CONCLUSION: Bis(7)-tacrine possesses remarkable neuroprotective activities against retinal excitotoxicity through inhibition of NMDA receptors.

Entities:  

Keywords:  N-methyl-D-aspartate receptors; bis(7)-tacrine; excitotoxicity; neuroprotection

Year:  2011        PMID: 22553626      PMCID: PMC3340694          DOI: 10.3980/j.issn.2222-3959.2011.02.03

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  13 in total

1.  Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity.

Authors:  Hongjun Fu; Wenming Li; Jialie Luo; Nelson T K Lee; Mingtao Li; Karl W K Tsim; Yuanping Pang; Moussa B H Youdim; Yifan Han
Journal:  Biochem Biophys Res Commun       Date:  2007-11-26       Impact factor: 3.575

Review 2.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

3.  Multifunctional drugs as neurotherapeutics.

Authors:  Cornelis J Van der Schyf; Moussa B H Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

4.  Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage.

Authors:  Masamitsu Shimazawa; Tetsumori Yamashima; Neeraj Agarwal; Hideaki Hara
Journal:  Brain Res       Date:  2005-08-16       Impact factor: 3.252

Review 5.  Possible role of excitotoxicity in the pathogenesis of glaucoma.

Authors:  Robert J Casson
Journal:  Clin Exp Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 4.207

6.  Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat.

Authors:  E Aizenman; M P Frosch; S A Lipton
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

7.  Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.

Authors:  Kate E Gilling; Claudia Jatzke; Mirko Hechenberger; Chris G Parsons
Journal:  Neuropharmacology       Date:  2009-01-21       Impact factor: 5.250

Review 8.  Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets.

Authors:  Wenming Li; Marvin Mak; Hualiang Jiang; Qinwen Wang; Yuanping Pang; Kaixian Chen; Yifan Han
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

9.  Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors.

Authors:  Yu-Wei Liu; Chao-Ying Li; Jia-Lie Luo; Wen-Ming Li; Hong-Jun Fu; Yuan-Zhi Lao; Li-Jiang Liu; Yuan-Ping Pang; Donald C Chang; Zhi-Wang Li; Robert W Peoples; Yong-Xun Ai; Yi-Fan Han
Journal:  Biochem Biophys Res Commun       Date:  2008-03-06       Impact factor: 3.575

Review 10.  Neuroprotection: extrapolating from neurologic diseases to the eye.

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  Am J Ophthalmol       Date:  2009-05-23       Impact factor: 5.258

View more
  3 in total

1.  A Small Organic Compound Mimicking the L1 Cell Adhesion Molecule Promotes Functional Recovery after Spinal Cord Injury in Zebrafish.

Authors:  Sudhanshu Sahu; Zhihua Zhang; Rong Li; Junkai Hu; Huifan Shen; Gabriele Loers; Yanqin Shen; Melitta Schachner
Journal:  Mol Neurobiol       Date:  2017-01-09       Impact factor: 5.590

Review 2.  Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma.

Authors:  Jiahua Fang; Fagang Jiang; Jingbo Li; Yanhua Zhu
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

Review 3.  Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.

Authors:  Andrew J Payne; Simon Kaja; Yuliya Naumchuk; Nancy Kunjukunju; Peter Koulen
Journal:  Int J Mol Sci       Date:  2014-01-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.